Specializing In
- Diabetes
- Diabetes and High Blood Pressure
- Diabetes Mellitus: Type 1 & 2
- Diabetes Related to Cystic Fibrosis
- Diabetes Related to Transplant
- Hypoglycemia
- Polycystic Ovarian Syndrome
Biography
Dr. McLaughlin graduated from Stanford University with honors and distinction in Human Biology, obtained a MS in Public Health at UC Berkeley, and MD at UC San Francisco. She completed her residency in Internal Medicine at Santa Clara Valley Medical Center and her fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University School of Medicine. She is currently a clinician investigator who maintains an active clinic for patients with complicated type 1, type 2, or other forms of diabetes, polycystic ovarian disease, and hypoglcyemia. Her clinical research program includes human studies on obesity, regional fat distribution, and the role of adipocytes and adipose tissue immune cells in promoting insulin resistance and type 2 diabetes. She also conducts studies on the role of incretin hormones in glucose metabolism and postbariatric hypoglycemia, and the use of continuous glucose monitoring and multi-omics methods to define metabolic sub-phenotypes and precision diets for individuals with prediabetes and type 2 diabetes.
View Full Biography
Professional Summary
Education & Certifications
- Board Certification: American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism (1999)
- Fellowship: Stanford University Endocrinology Fellowship (2000) CA
- Residency: Santa Clara Valley Medical Center Internal Medicine Residency (1997) CA
-
- Internship: Santa Clara Valley Medical Center (1995) CA United States of America
- Medical Education: UCSF Medical Center (1994) CA
- M.S., Stanford University, Epidemiology (2004)
- M.D., U.C. San Francisco, Medicine (1994)
- M.S., U.C. Berkeley, Public Health (1992)
- B.A., Stanford University, Human Biology (1988)
Honors & Awards
- Intern of the Year, Santa Clara Valley Medical Center (1995)
- Junior Physician Investigator Award, American Federation for Medical Research (2004)
- K23 Award, NIH (2000)
-
- Young Investigators’ Forum Finalist, Northwestern University Feinberg School of Medicine (2005)
Memberships
- Member, Endocrine Society (1997 - Present)
- Member, American Diabetes Association (1997 - Present)
- Steering Committee Member, World Congress on Insulin Resistance (2007 - Present)
-
Administrative Appointments
- Appointments and Promotions Committee, Stanford University (2018 - Present)
- Diabetes Task Force, Chair, Stanford Hospital (2004 - Present)
- GCRC Advisory Committee, member, Stanford University (2003 - Present)
-
- SPARK Member, Stanford University School of Medicine (2015 - Present)
- Women's Health and Sex Differences in Medicine Committee Member, Stanford University (2013 - Present)
Publications
-
Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women
McLaughlin, T., Abbasi, F., Carantoni, M., Schaaf, P., & Reaven, G. (1999). Differences in insulin resistance do not predict weight loss in response to hypocaloric diets in healthy obese women. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 84(2), 578–581. -
Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers
Chen, N. G., Abbasi, F., Lamendola, C., McLaughlin, T., Cooke, J. P., Tsao, P. S., & Reaven, G. M. (1999). Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers. CIRCULATION, 100(9), 940–943. -
Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women
Abbasi, F., McLaughlin, T., Lamendola, C., Lipinska, I., Tofler, G., & Reaven, G. M. (1999). Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 19(11), 2818–2821. -
-
Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers
Abbasi, F., McLaughlin, T., Lamendola, C., Yeni-Komshian, H., Tanaka, A., Wang, T., … Reaven, G. M. (1999). Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 84(11), 3903–3906. -
Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance
Abbasi, F., McLaughlin, T., Lamendola, C., & Reaven, G. M. (2000). Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. METABOLISM-CLINICAL AND EXPERIMENTAL, 49(2), 151–154. -
The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers
Abbasi, F., McLaughlin, T., Lamendola, C., & Reaven, G. M. (2000). The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 85(3), 1251–1254. -
Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index
Abbasi, F., Carantoni, M., McLaughlin, T., & Reaven, G. M. (2000). Plasma insulin concentration is more tightly linked to plasma leptin concentration than is the body mass index. METABOLISM-CLINICAL AND EXPERIMENTAL, 49(4), 544–547. -
Insulin resistance and hypertension - Patients in double jeopardy for cardiovascular disease
McLaughlin, T., & Reaven, G. (2000). Insulin resistance and hypertension - Patients in double jeopardy for cardiovascular disease. GERIATRICS, 55(6), 28-? -
Carbohydrate-induced hypertriglyceridemia: An insight into the link between plasma insulin and triglyceride concentrations
McLaughlin, T., Abbasi, F., Lamendola, C., Yeni-Komshian, H., & Reaven, G. (2000). Carbohydrate-induced hypertriglyceridemia: An insight into the link between plasma insulin and triglyceride concentrations. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 85(9), 3085–3088. -
High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk
Abbasi, F., McLaughlin, T., Lamendola, C., Kim, H. S., Tanaka, A., Wang, T., … Reaven, G. M. (2000). High carbohydrate diets, triglyceride-rich lipoproteins, and coronary heart disease risk. AMERICAN JOURNAL OF CARDIOLOGY, 85(1), 45–48. -
Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women
Reaven, G. M., Abbasi, F., Bernhart, S., Coulston, A., Darnell, B., Dashti, N., … Segrest, J. (2001). Insulin resistance, dietary cholesterol, and cholesterol concentration in postmenopausal women. METABOLISM-CLINICAL AND EXPERIMENTAL, 50(5), 594–597. -
Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women
McLaughlin, T., Abbasi, F., Kim, H. S., Lamendola, C., Schaaf, P., & Reaven, G. (2001). Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women. METABOLISM-CLINICAL AND EXPERIMENTAL, 50(7), 795–800. -
Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity
McLaughlin, T., Abbasi, F., Lamendola, C., Kim, H. S., & Reaven, G. M. (2001). Metabolic changes following sibutramine-assisted weight loss in obese individuals: Role of plasma free fatty acids in the insulin resistance of obesity. METABOLISM-CLINICAL AND EXPERIMENTAL, 50(7), 819–24. -
Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women
Kim, H. S., Abbasi, F., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2001). Effect of insulin resistance on postprandial elevations of remnant lipoprotein concentrations in postmenopausal women. AMERICAN JOURNAL OF CLINICAL NUTRITION, 74(5), 592–95. -
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus
Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., … Tsao, P. S. (2001). Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. AMERICAN JOURNAL OF CARDIOLOGY, 88(10), 1201-? -
Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone
Cataldo, N. A., Abbasi, F., McLaughlin, T. L., Lamendola, C., & Reaven, G. M. (2001). Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone. FERTILITY AND STERILITY, 76(5), 1057–1059. -
Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor
Stuhlinger, M. C., Abbasi, F., Chu, J. W., Lamendola, C., McLaughlin, T. L., Cooke, J. P., … Tsao, P. S. (2002). Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 287(11), 1420–26. -
Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes
Asagami, T., Abbasi, F., Stuelinger, M., Lamendola, C., McLaughlin, T., Cooke, J. P., … Tsao, P. S. (2002). Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes. METABOLISM-CLINICAL AND EXPERIMENTAL, 51(7), 843–846. -
Relationship between obesity, insulin resistance, and coronary heart disease risk
Abbasi, F., Brown, B. W., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2002). Relationship between obesity, insulin resistance, and coronary heart disease risk. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 40(5), 937–943. -
Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl- coenzyme a reductase inhibitor treatment of combined dyslipidemia
McLaughlin, T., Abbasi, F., Lamendola, C., Leary, E., & Reaven, G. M. (2002). Comparison in patients with type 2 diabetes of fibric acid versus hepatic hydroxymethyl glutaryl- coenzyme a reductase inhibitor treatment of combined dyslipidemia. METABOLISM-CLINICAL AND EXPERIMENTAL, 51(10), 1355–59. -
Differentiation between obesity and insulin resistance in the association with C-reactive protein
McLaughlin, T., Abbasi, F., Lamendola, C., Liang, L., Reaven, G., Schaaf, P., & Reaven, P. (2002). Differentiation between obesity and insulin resistance in the association with C-reactive protein. CIRCULATION, 106(23), 2908–12. -
Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology
Chu, J. W., Abbasi, F., Kulkarni, K. R., Lamendola, C., McLaughlin, T. L., Scalisi, J. N., & Reaven, G. M. (2003). Multiple lipoprotein abnormalities associated with insulin resistance in healthy volunteers are identified by the vertical auto profile-II methodology. CLINICAL CHEMISTRY, 49(6), 1014–17. -
Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents
Chu, J. W., Abbasi, F., McLaughlin, T. L., Lamendola, C., Schaaf, P., Carlson, T. H., … Reaven, G. M. (2003). Lipoprotein risk factors for cardiovascular disease in patients with type 2 diabetes mellitus treated with oral antihyperglycaemic agents. DIABETES OBESITY & METABOLISM, 5(5), 333–337. -
Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance
Tuan, C. Y., Abbasi, F., Lamendola, C., McLaughlin, T., & Reaven, G. (2003). Usefulness of plasma glucose and insulin concentrations in identifying patients with insulin resistance. AMERICAN JOURNAL OF CARDIOLOGY, 92(5), 606–10. -
Use of metabolic markers to identify overweight individuals who are insulin resistant
McLaughlin, T., Abbasi, F., Cheal, K., Chu, J., Lamendola, C., & Reaven, G. (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant. ANNALS OF INTERNAL MEDICINE, 139(10), 802–9. -
Obesity, insulin resistance, and cardiovascular disease
Reaven, G., Abbasi, F., & McLaughlin, T. (2004). Obesity, insulin resistance, and cardiovascular disease. RECENT PROGRESS IN HORMONE RESEARCH, VOL 59, 59, 207–23. -
Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus
Abbasi, F., Chu, J. W., McLaughlin, T., Lamendola, C., Leary, E. T., & Reaven, G. M. (2004). Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. METABOLISM-CLINICAL AND EXPERIMENTAL, 53(2), 159–64. -
Discrimination between obesity and insulin resistance in the relationship with adiponectin
Abbasi, F., Chu, J. W., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G. M., & Reaven, P. D. (2004). Discrimination between obesity and insulin resistance in the relationship with adiponectin. DIABETES, 53(3), 585–90. -
Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women
Abbasi, F., Lamendola, C., McLaughlin, T., Hayden, J., Reaven, G. M., & Reaven, P. D. (2004). Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. METABOLISM-CLINICAL AND EXPERIMENTAL, 53(3), 280–83. -
Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals
McLaughlin, T., Allison, G., Abbasi, F., Lamendola, C., & Reaven, G. (2004). Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. METABOLISM-CLINICAL AND EXPERIMENTAL, 53(4), 495–99. -
Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome
Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S. (2004). Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. DIABETES, 53(5), 1195–1200. -
Comparative effects of rosuvastatin and gomfibrozil on glucose, insulin, and lipid metabolism in insulin m resistant, nondiabetic patients with combined dyslipidemia
Lamendola, C., Abbasi, F., Chu, J. W., Hutchinson, H., Cain, V., Leary, E., … Reaven, G. (2005). Comparative effects of rosuvastatin and gomfibrozil on glucose, insulin, and lipid metabolism in insulin m resistant, nondiabetic patients with combined dyslipidemia. AMERICAN JOURNAL OF CARDIOLOGY, 95(2), 189–93. -
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals
Kim, S. H., Abbasi, F., Chu, J. W., McLaughlin, T. L., Lamendola, C., Polonsky, K. S., & Reaven, G. M. (2005). Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals. DIABETES, 54(8), 2447–52. -
Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., … Krauss, R. M. (2005). Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? AMERICAN JOURNAL OF CARDIOLOGY, 96(3), 399–404. -
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome
Cataldo, N. A., Abbasi, F., McLaughlin, T. L., Basina, M., Fechner, P. Y., Giudice, L. C., & Reaven, G. M. (2006). Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome. HUMAN REPRODUCTION, 21(1), 109–20. -
Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects.
Chu, J. W., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Tsao, P. S. (2005). Effect of rosiglitazone treatment on circulating vascular and inflammatory markers in insulin-resistant subjects. Diabetes & Vascular Disease Research , 2(1), 37–41. -
Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes
Abbasi, F., Chang, S. A., Chu, J. W., Ciaraldi, T. P., Lamendola, C., McLaughlin, T., … Reaven, P. D. (2006). Improvements in insulin resistance with weight loss, in contrast to rosiglitazone, are not associated with changes in plasma adiponectin or adiponectin multimeric complexes. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 290(1), R139–R144. -
Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss
McLaughlin, T., Stuhlinger, M., Lamendola, C., Abbasi, F., Bialek, J., Reaven, G. M., & Tsao, P. S. (2006). Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 91(5), 1896–1900. -
The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers
Abbasi, F., Farin, H. M. F., Lamendola, C., McLaughlin, T., Schwartz, E. A., Reaven, G. M., & Reaven, P. D. (2006). The relationship between plasma adiponectin concentration and insulin resistance is altered in smokers. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 91(12), 5002–7. -
Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults
McLaughlin, T., Carter, S., Lamendola, C., Abbasi, F., Yee, G., Schaaf, P., … Reaven, G. (2006). Effects of moderate variations in macronutrient composition on weight loss and reduction in cardiovascular disease risk in obese, insulin-resistant adults. AMERICAN JOURNAL OF CLINICAL NUTRITION, 84(4), 813–21. -
The relationship between insulin resistance and dyslipidaemia in cigarette smokers
Farin, H. M. F., Abbasi, F., Kim, S. H., Lamendola, C., McLaughlin, T., & Reaven, G. M. (2007). The relationship between insulin resistance and dyslipidaemia in cigarette smokers. DIABETES OBESITY & METABOLISM, 9(1), 65–69. -
Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults
Ryan, M. C., Carter, S., Abbasi, F., McLaughlin, T. L., & Lamendola, C. (2007). Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. DIABETES CARE, 30(5), 1075–80. -
Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals - Effect of differences in insulin sensitivity
McLaughlin, T., Abbasi, F., Lamendola, C., & Reaven, G. (2007). Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals - Effect of differences in insulin sensitivity. ARCHIVES OF INTERNAL MEDICINE, 167(7), 642–48. -
Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes - Comparison of moderate fat versus carbohydrate reductions
McLaughlin, T., Carter, S., Lamendola, C., Abbasi, F., Schaaf, P., Basina, M., & Reaven, G. (2007). Clinical efficacy of two hypocaloric diets that vary in overweight patients with type 2 diabetes - Comparison of moderate fat versus carbohydrate reductions. DIABETES CARE, 30(7), 1877–79. -
Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis
McLaugblin, T., Sherman, A., Tsao, P., Gonzalez, O., Yee, G., Lamendola, C., … Cusbman, S. W. (2007). Enhanced proportion of small adipose cells in insulin-resistant vs insulin-sensitive obese individuals implicates impaired adipogenesis. DIABETOLOGIA, 50(8), 1707–1715. -
Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women
Palaniappan, L. P., Kwan, A. C., Abbasi, F., Lamendola, C., McLaughlin, T. L., & Reaven, G. M. (2007). Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women. METABOLISM-CLINICAL AND EXPERIMENTAL, 56(7), 899–904. -
Persistence of improvement in insulin sensitivity following a dietary weight loss programme
McLaughlin, T., Schweitzer, P., Carter, S., Yen, C.-G., Lamendola, C., Abbasi, F., & Reaven, G. (2008). Persistence of improvement in insulin sensitivity following a dietary weight loss programme. DIABETES OBESITY & METABOLISM, 10(12), 1186–1194. -
Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers
Abbasi, F., Farin, H. M. F., Lemendola, C., McGraw, L., McLaughlin, T., & Reaven, G. M. (2008). Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers. METABOLISM-CLINICAL AND EXPERIMENTAL, 57(8), 1108–14. -
Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women
McLaughlin, T., Deng, A., Gonzales, O., AILLAUD, M., Yee, G., Lamendola, C., … Tsao, P. S. (2008). Insulin resistance is associated with a modest increase in inflammation in subcutaneous adipose tissue of moderately obese women. DIABETOLOGIA, 51(12), 2303–2308. -
Clinical experience with a relatively low carbohydrate, calorie-restricted diet improves insulin sensitivity and associated metabolic abnormalities in overweight, insulin resistant South Asian Indian women
Backes, A. C., Abbasi, F., Lamendola, C., McLaughlin, T. L., Reaven, G., & Palaniappan, L. P. (2008). Clinical experience with a relatively low carbohydrate, calorie-restricted diet improves insulin sensitivity and associated metabolic abnormalities in overweight, insulin resistant South Asian Indian women. ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 17(4), 669–71. -
Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without Neuroglycopenia
Kim, S. H., Liu, T. C., Abbasi, F., Lamendola, C., Morton, J. M., Reaven, G. M., & McLaughlin, T. L. (2009). Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or Without Neuroglycopenia. OBESITY SURGERY, 19(11), 1550–56. -
Differential Intra-abdominal Adipose Tissue Profiling in Obese, Insulin-resistant Women
Liu, A., McLaughlin, T., Liu, T., Sherman, A., Yee, G., Abbasi, F., … Tsao, P. S. (2009). Differential Intra-abdominal Adipose Tissue Profiling in Obese, Insulin-resistant Women. OBESITY SURGERY, 19(11), 1564–73. -
Inflammation in subcutaneous adipose tissue: relationship to adipose cell size
McLaughlin, T., Deng, A., Yee, G., Lamendola, C., Reaven, G., Tsao, P. S., … Sherman, A. (2010). Inflammation in subcutaneous adipose tissue: relationship to adipose cell size. DIABETOLOGIA, 53(2), 369–377. -
Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue
McLaughlin, T. M., Liu, T., Yee, G., Abbasi, F., Lamendola, C., Reaven, G. M., … Sherman, A. (2010). Pioglitazone Increases the Proportion of Small Cells in Human Abdominal Subcutaneous Adipose Tissue. OBESITY, 18(5), 926–31. -
Using Pre-existing Microarray Datasets to Increase Experimental Power: Application to Insulin Resistance
Daigle, B. J., Deng, A., McLaughlin, T., Cushman, S. W., Cam, M. C., Reaven, G., … Altman, R. B. (2010). Using Pre-existing Microarray Datasets to Increase Experimental Power: Application to Insulin Resistance. PLOS COMPUTATIONAL BIOLOGY, 6(3). -
Glucose-Stimulated Insulin Secretion in Gastric Bypass Patients with Hypoglycemic Syndrome: No Evidence for Inappropriate Pancreatic beta-cell Function
Kim, S. H., Abbasi, F., Lamendola, C., Reaven, G. M., & McLaughlin, T. (2010). Glucose-Stimulated Insulin Secretion in Gastric Bypass Patients with Hypoglycemic Syndrome: No Evidence for Inappropriate Pancreatic beta-cell Function. OBESITY SURGERY, 20(8), 1110–16. -
Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats
Liu, A., Sonmez, A., Yee, G., Bazuine, M., Arroyo, M., Sherman, A., … Tsao, P. (2010). Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats. DIABETES & VASCULAR DISEASE RESEARCH, 7(4), 311–18. -
B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies
Winer, D. A., Winer, S., Shen, L., Wadia, P. P., Yantha, J., Paltser, G., … Engleman, E. G. (2011). B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. NATURE MEDICINE, 17(5), 610–U134. -
Preferential Fat Deposition in Subcutaneous Versus Visceral Depots Is Associated with Insulin Sensitivity
McLaughlin, T., Lamendola, C., Liu, A., & Abbasi, F. (2011). Preferential Fat Deposition in Subcutaneous Versus Visceral Depots Is Associated with Insulin Sensitivity. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 96(11), E1756–E1760. -
Subcutaneous Adipose Cell Size and Distribution: Relationship to Insulin Resistance and Body Fat
McLaughlin, T., Lamendola, C., Coghlan, N., Liu, T. C., Lerner, K., Sherman, A., & Cushman, S. W. (2014). Subcutaneous Adipose Cell Size and Distribution: Relationship to Insulin Resistance and Body Fat. OBESITY, 22(3), 673–680. -
Does Synchronizing Initiation of Therapy Affect Adherence to Concomitant Use of Antihypertensive and Lipid-Lowering Therapy?
Agarwal, S., Tang, S. S. K., Rosenberg, N., Pettitt, D., McLaughlin, T., Joyce, A., & Schwartz, J. S. (2009). Does Synchronizing Initiation of Therapy Affect Adherence to Concomitant Use of Antihypertensive and Lipid-Lowering Therapy? AMERICAN JOURNAL OF THERAPEUTICS, 16(2), 119–126. -
Rosuvastatin is efficacious as monotherapy in patients with combined dyslipidemia
Abbasi, F., Chu, J. W., Lamendola, C., McLaughlin, T., Cain, V., Hutchinson, H. G., & Reaven, G. M. (2004). Rosuvastatin is efficacious as monotherapy in patients with combined dyslipidemia. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 43(5), 480A–480A. -
Rosiglitazone in insulin-resistant women with polycystic ovary syndrome: effects on ovarianfunction and metabolism
Cataldo, N. A., Abbasi, F., McLaughlin, T. L., Chu, J. W., Basina, M., Fechner, P. Y., … Giudice, L. C. (2003). Rosiglitazone in insulin-resistant women with polycystic ovary syndrome: effects on ovarianfunction and metabolism. OXFORD UNIV PRESS. -
Small adipocytes: implications for inflammation and insulin resistance
Sonmez, A., Sung, K., Yee, G., Deng, A., Mullen, S., McLaughlin, T., … Tsao, P. (2007). Small adipocytes: implications for inflammation and insulin resistance. OXFORD UNIV PRESS. -
Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation
Khazanie, P., Haddad, F., Simos, A. M., Pham, M., Weisshaar, D. M., Desai, S. V., … Fearon, W. (2009). Microvascular Dysfunction and Suboptimal Glycemic Control Predicts Poor Outcome Following Heart Transplantation. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 53(10), A182–A182. -
Differential effects of two hypocaloric diets (restricted carbohydrate versus restricted fat) on hepatic aminotransferases in obese insulin resistant individuals: An intervention study
Ryan, M. C., McLaughlin, T. L., & Reaven, G. M. (2006). Differential effects of two hypocaloric diets (restricted carbohydrate versus restricted fat) on hepatic aminotransferases in obese insulin resistant individuals: An intervention study. HEPATOLOGY, 44(4), 646A–646A. -
The Winged Helix Transcription Factor Foxa3 Regulates Adipocyte Differentiation and Depot-Selective Fat Tissue Expansion
Xu, L., Panel, V., Ma, X., Du, C., Hugendubler, L., Gavrilova, O., … Muellera, E. (2013). The Winged Helix Transcription Factor Foxa3 Regulates Adipocyte Differentiation and Depot-Selective Fat Tissue Expansion. MOLECULAR AND CELLULAR BIOLOGY, 33(17), 3392–99. -
Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls
McLaughlin, T., Abbasi, F., Lamendola, C., Frayo, R. S., & Cummings, D. E. (2004). Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 89(4), 1630–1635. -
Reversible Hyperinsulinemic Hypoglycemia after Gastric Bypass: A Consequence of Altered Nutrient Delivery
McLaughlin, T., Peck, M., Holst, J., & Deacon, C. (2010). Reversible Hyperinsulinemic Hypoglycemia after Gastric Bypass: A Consequence of Altered Nutrient Delivery. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 95(4), 1851–55. -
Use of a two-stage insulin infusion study to assess the relationship between insulin suppression of lipolysis and insulin-mediated glucose uptake in overweight/obese, nondiabetic women
McLaughlin, T., Yee, G., Glassford, A., Lamendola, C., & Reauen, G. (2011). Use of a two-stage insulin infusion study to assess the relationship between insulin suppression of lipolysis and insulin-mediated glucose uptake in overweight/obese, nondiabetic women. METABOLISM-CLINICAL AND EXPERIMENTAL, 60(12), 1741–47. -
T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans
McLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., … Engleman, E. (2014). T-Cell Profile in Adipose Tissue Is Associated With Insulin Resistance and Systemic Inflammation in Humans. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 34(12), 2637–43. -
In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans.
Allister, C. A., Liu, L.-F., Lamendola, C. A., Craig, C. M., Cushman, S. W., Hellerstein, M. K., & McLaughlin, T. L. (2015). In vivo 2H2O administration reveals impaired triglyceride storage in adipose tissue of insulin-resistant humans. Journal of Lipid Research, 56(2), 435–39. -
The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue
Liu, L. F., Kodama, K., Wei, K., Tolentino, L. L., Choi, O., Engleman, E. G., … McLaughlin, T. (2015). The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue. DIABETOLOGIA, 58(7), 1579–86. -
Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo
Beysen, C., Turner, H. C., Murphy, E. J., Awada, M., McLaughlin, T., Turner, S. M., … Hellerstein, M. K. (2007). Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo. DIABETES CARE, 30(5), 1143–1149. -
T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans.
McLaughlin, T., Liu, L.-F., Lamendola, C., Shen, L., Morton, J., Rivas, H., … Engleman, E. (2014). T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(12), 2637–43. -
Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans
McLaughlin, T., Craig, C., Liu, L.-F., Perelman, D., Allister, C., Spielman, D., & Cushman, S. W. (2016). Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans. DIABETES, 65(5), 1245–54. -
Pasireotide Induced Adrenal Insufficiency.
Weaver, K., Craig, C., & McLaughlin, T. (2016). Pasireotide Induced Adrenal Insufficiency. Clinical Endocrinology. -
A glucocorticoid- and diet-responsive pathway toggles adipocyte precursor cell activity in vivo.
Wong, J. C., Krueger, K. C., Costa, M. J., Aggarwal, A., Du, H., McLaughlin, T. L., & Feldman, B. J. (2016). A glucocorticoid- and diet-responsive pathway toggles adipocyte precursor cell activity in vivo. Science Signaling, 9(451), ra103-? -
Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.
Perelman, D., Coghlan, N., Lamendola, C., Carter, S., Abbasi, F., & McLaughlin, T. (2016). Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome. Gynecological Endocrinology , 1–4. -
Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information.
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Schüssler-Fiorenza Rose, S. M., … Snyder, M. P. (2017). Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information. PLoS Biology, 15(1). -
Adipose tissue macrophages impair preadipocyte differentiation in humans.
Liu, L. F., Craig, C. M., Tolentino, L. L., Choi, O., Morton, J., Rivas, H., … McLaughlin, T. (2017). Adipose tissue macrophages impair preadipocyte differentiation in humans. PloS One, 12(2). -
Role of innate and adaptive immunity in obesity-associated metabolic disease
McLaughlin, T., Ackerman, S. E., Shen, L., & Engleman, E. (2017). Role of innate and adaptive immunity in obesity-associated metabolic disease. JOURNAL OF CLINICAL INVESTIGATION, 127(1), 5–13. -
Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig, C. M., Liu, L.-F., Deacon, C. F., Holst, J. J., & McLaughlin, T. L. (2017). Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia. Diabetologia, 60(3), 531–40. -
Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome
Perelman, D., Coghlan, N., Lamendola, C., Carter, S., Abbasi, F., & McLaughlin, T. (2017). Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome. GYNECOLOGICAL ENDOCRINOLOGY, 33(4), 324–27. -
Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information
Li, X., Dunn, J., Salins, D., Zhou, G., Zhou, W., Rose, S. M. S.-F., … Snyder, M. P. (2017). Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information. PLOS BIOLOGY, 15(1). -
Integrative Personal Omics Profiles during Periods of Weight Gain and Loss.
Piening, B. D., Zhou, W., Contrepois, K., Röst, H., Gu Urban, G. J., Mishra, T., … Snyder, M. P. (2018). Integrative Personal Omics Profiles during Periods of Weight Gain and Loss. Cell Systems. -
Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or without Neuroglycopenia
Kim, S. H., Liu, T. C., Abbasi, F., Lamendola, C., Morton, J. M., Reaven, G. M., & McLaughlin, T. (2009). Plasma Glucose and Insulin Regulation Is Abnormal Following Gastric Bypass Surgery with or without Neuroglycopenia. DIABETES. AMER DIABETES ASSOC. -
Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia
Craig, C. M., Liu, L.-fen, Thi Nguyen, Price, C., Bingham, J., & McLaughlin, T. L. (2018). Efficacy and pharmacokinetics of subcutaneous exendin (9-39) in patients with post-bariatric hypoglycaemia. DIABETES OBESITY & METABOLISM, 20(2), 352–61. -
Glucotypes reveal new patterns of glucose dysregulation.
Hall, H., Perelman, D., Breschi, A., Limcaoco, P., Kellogg, R., McLaughlin, T., & Snyder, M. (2018). Glucotypes reveal new patterns of glucose dysregulation. PLoS Biology, 16(7), e2005143. -
Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
Salehi, M., Vella, A., McLaughlin, T., & Patti, M.-E. (2018). Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 103(8), 2815–26. -
T-Cells in Human Subcutaneous Adipose Tissue
Mclaughlin, T., Liu, L. F., Craig, C., Perelman, D., Choi, O., Tolentino, L., & Engleman, E. (2017). T-Cells in Human Subcutaneous Adipose Tissue. DIABETES, 66, A90. -
Subcutaneous Exendin (9-39) Effectively Treats Postbariatric Hyper insulinemic Hypoglycemia
Craig, C. M., & Mclaughlin, T. L. (2016). Subcutaneous Exendin (9-39) Effectively Treats Postbariatric Hyper insulinemic Hypoglycemia. DIABETES, 65, A7–A8. -
Macro fat and micro fat: insulin sensitivity and gender dependent response of adipose tissue to isocaloric diet change
Li, Y., Gaillard, J. R., McLaughlin, T., Sorensen, T. I. A., & Periwal, V. (2015). Macro fat and micro fat: insulin sensitivity and gender dependent response of adipose tissue to isocaloric diet change. ADIPOCYTE, 4(4), 256–63. -
Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control.
Nagy, N., Sunkari, V. G., Kaber, G., Hasbun, S., Lam, D. N., Speake, C., … Bollyky, P. L. (2018). Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control. Matrix Biology : Journal of the International Society for Matrix Biology. -
High Frequency Actionable Pathogenic Exome Variants in an Average-Risk Cohort.
Rego, S., Dagan-Rosenfeld, O., Zhou, W., Sailani, M. R., Limcaoco, P., Colbert, E., … Snyder, M. P. (2018). High Frequency Actionable Pathogenic Exome Variants in an Average-Risk Cohort. Cold Spring Harbor Molecular Case Studies. -
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia.
Mulla, C. M., Goldfine, A. B., Dreyfuss, J. M., Houten, S., Pan, H., Pober, D. M., … Patti, M.-E. (2019). Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia. Obesity Surgery. -
Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women.
Allister-Price, C., Craig, C. M., Spielman, D., Cushman, S. S., & McLaughlin, T. L. (2018). Metabolic markers, regional adiposity, and adipose cell size: relationship to insulin resistance in African-American as compared with Caucasian women. International Journal of Obesity (2005). -
A longitudinal big data approach for precision health.
Schüssler-Fiorenza Rose, S. M., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., … Snyder, M. P. (2019). A longitudinal big data approach for precision health. Nature Medicine, 25(5), 792–804. -
A longitudinal big data approach for precision health
Rose, S. M. S.-F., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., … Snyder, M. P. (2019). A longitudinal big data approach for precision health. NATURE MEDICINE, 25(5), 792-+. -
Longitudinal multi-omics of host-microbe dynamics in prediabetes.
Zhou, W., Sailani, M. R., Contrepois, K., Zhou, Y., Ahadi, S., Leopold, S. R., … Snyder, M. (2019). Longitudinal multi-omics of host-microbe dynamics in prediabetes. Nature, 569(7758), 663–71. -
Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia
Mulla, C. M., Goldfine, A. B., Dreyfuss, J. M., Houten, S., Pan, H., Pober, D. M., … Patti, M.-E. (2019). Plasma FGF-19 Levels are Increased in Patients with Post-Bariatric Hypoglycemia. OBESITY SURGERY, 29(7), 2092–99. -
Generating biosimilar therapeutic drugs through innovative technology and operational excellence
Zhou, B. (2019). Generating biosimilar therapeutic drugs through innovative technology and operational excellence. NATURE, 569(7755). -
Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control
Nagy, N., Sunkari, V. G., Kaber, G., Hasbun, S., Lam, D. N., Speake, C., … Bollyky, P. L. (2019). Hyaluronan levels are increased systemically in human type 2 but not type 1 diabetes independently of glycemic control. MATRIX BIOLOGY, 80, 46–58. -
FAM13A affects body fat distribution and adipocyte function.
Fathzadeh, M., Li, J., Rao, A., Cook, N., Chennamsetty, I., Seldin, M., … Knowles, J. W. (2020). FAM13A affects body fat distribution and adipocyte function. Nature Communications, 11(1), 1465. -
Safety, Efficacy and Pharmacokinetics of Repeat Subcutaneous Dosing of Avexitide (Exendin 9-39) for Treatment of Post-Bariatric Hypoglycemia.
Tan, M., Lamendola, C., Luong, R., McLaughlin, T., & Craig, C. (2020). Safety, Efficacy and Pharmacokinetics of Repeat Subcutaneous Dosing of Avexitide (Exendin 9-39) for Treatment of Post-Bariatric Hypoglycemia. Diabetes, Obesity & Metabolism. -
Guidelines for gastrostomy tube placement and enteral nutrition in patients with severe, refractory hypoglycemia after gastric bypass.
Zanley, E., Shah, N. D., Craig, C., Lau, J. N., Rivas, H., & McLaughlin, T. (2020). Guidelines for gastrostomy tube placement and enteral nutrition in patients with severe, refractory hypoglycemia after gastric bypass. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery. -
Mechanisms Underlying Glycemic Reduction Following Roux-enY Gastric Bypass Surgery: Foregut Versus Hindgut Contributions
Craig, C. M., & McLaughlin, T. L. (2021). Mechanisms Underlying Glycemic Reduction Following Roux-enY Gastric Bypass Surgery: Foregut Versus Hindgut Contributions. METABOLISM-CLINICAL AND EXPERIMENTAL. W B SAUNDERS CO-ELSEVIER INC. -
PREVENT: A Randomized, Placebo-Controlled Crossover Trial of Avexitide for Treatment of Post-Bariatric Hypoglycemia.
Craig, C. M., Lawler, H. M., Lee, C. J., Tan, M., Davis, D. B., Tong, J., … Porter, L. (2021). PREVENT: A Randomized, Placebo-Controlled Crossover Trial of Avexitide for Treatment of Post-Bariatric Hypoglycemia. The Journal of Clinical Endocrinology and Metabolism. -
Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia.
Craig, C. M., & McLaughlin, T. L. (2021). Defining clinically important hypoglycemia in patients with postbariatric hypoglycemia. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery. -
Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge.
McLaughlin, T., Schnittger, I., Nagy, A., Zanley, E., Xu, Y., Song, Y., … Sacks, H. (2021). Relationship Between Coronary Atheroma, Epicardial Adipose Tissue Inflammation, and Adipocyte Differentiation Across the Human Myocardial Bridge. Journal of the American Heart Association, e021003.
-
Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin-resistant, female volunteers
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
Diabetes Care Program Palo Alto, CA
Palo Alto, CA
Diabetes Care Program
211 Quarry Rd
Palo Alto , CA 94304
Make An Appointment More Clinic Information Getting HereEndocrinology Clinic at Boswell Building Palo Alto, CA
Palo Alto, CA
Endocrinology Clinic at Boswell Building
300 Pasteur Dr, Fl 1 Ste A175
Palo Alto , CA 94305
Make An Appointment More Clinic Information Getting HereImportant Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Patient Reviews
(114 reviews)
She is an excellent and encouraging physician.
She is excellent!
She is thoughtful, very well-informed and looks for specific ways to be helpful to me. An excellent doctor who has guided me to successful dealing with a chronic vonfition.
Dr. McLaughlin is so kind and listens!
I appreciate all of the time she spends with me and advice on helping me!
Appreciate her concern
She is an excellent doctor and she take care of me very well!
She is the best endocrinologist I have had in my entire life. Cutting edge work. I am grateful to have her manage my care.
She’s awesome!
Highly professional and very knowledgeable professor . Highly educated and very good in understand patient needs and problems. Always responsive and helpful, very friendly and take patient under immediate supervision and care. Will recommend her without any second of thought
She is great, but I would appreciate it if she would check all messages and info I send her before we meet
Excellent doctor
I really like her caring personality for me (the patient)
She is an excellent doctor. Often use up-to-date medicine to treat patient!
Always helpful and attentive. Thinks outside the box.
she's excellent
She's helpful
I appreciate her sincere concern
She is very good
Dr. McLaughlin is a excellent doctor! She takes care me well!
Dr. McLaughlin is an excellent doctor
Thorough, caring, very experienced physician
Dr McLaughlin continues to give the finest patient experience. She knows her patients, their history, and their needs. She is not a "paint by numbers" clinician... she treats the Whole Patient. I will forever be grateful that my journey with diabetes was shepherded by Tracey McLaughlin.
She is a very thoughtful and well-informed doctor who pays attention to individual circumstances in providing advice.
Dr Tracey Mclaughlin keeps me alive and has been doing so for a very long time!
VERY GOOD, KNOWLEDGEABLE, AND EASY TO UNDERSTAND. ALSO ASKS THE RIGHT QUESTIONS.
Thank you
Dr. Mclaughlin is extremely caring and compassionate and provides top notch medical care.
Dr. McLaughlin is attentive and helpful.
Dr McLaughlin is a really good endocrinologist. She has helped me gain control of CFRD.
she's very good at what she does
Thanks!
Dr. Mclaughlin is great. I've been her patient many years and she's thorough and interested in C.F. as well as the diabetic issues I see her for.
Dr. Mc Laughlin is knowledgeable, caring, and thoughtful.
She is very thorough and made sure I had a good plan for the next 3 months
Doctor McLaughlin is an amazing doctor! She really tried her best to ensure she answered all my questions and made me feel cared about and try to figure out what’s wrong! I have been going to doctors for 5 years trying to figure out what’s going on with me and so many just said they don’t know and passed me along to the next doctor. Doctor McLaughlin on the other hand, is trying to figure things out even-though my situation isn’t textbook easy and is researching and helping and brainstorming possible reasons. It made me feel very cared about and I really appreciated getting the support I’ve been looking for. It’s very easy to give up when doctors keep saying they don’t know but she made me have the courage to keep searching for answers!
She is amazing!!!!!!!!!!!!!! I can not be happier and feel more cared for by a doctor. She is rated at the top for all time best doctors I have seen. Really!!!!
Dr. McLaughlin is very good and knowledgeable, but I would love to feel that I can have plenty of time with her for all my questions and concerns. I would also appreciate explanations of test results and conditions with a little more detail.
Dr. McLaughlin and her assistant today were excellent. Friendly, helpful, and to the point.
She is a thoughtful knowledgeable and empathetic doctor. Her suggestions for managing my diabetes were precise and useful.
Everything thing quite well
Exceptional doctor with highest level of knowledge and amazing personality that perfectly engaging in her brilliant mind . Couldn’t wish myself better doctor to myself to fight for my very complicated situation. She is very thoughtful about her patients and takes care of every single issue without any hesitation. Adore her professionalism. Highly recommend by any level .
helpful
Have a real appreciation for her concerns and understanding
Dr. Mclaughlin has been my care provider for a long time and it's always good to see her. She knows my particular needs well and evaluates my ongoing treatment each time to best meet my needs.
McLaughlin was caring for me
She is a great doctor! Helpful and patient! Care of the patient!
She is always helpful
As I previously stated in a similar survey Dr. McLaughlin is an excellent endocrinologist who cares about her patients and their health.
Just getting to know this caregiver, but had a good visit with her.
I appreciate the caring attention I receive!
Thank you Dr. McLaughlin for your concern and your excellent care.
Blessings to you and your family. :)
She is very knowledgeable and a nice person. She listens well.
Excellent and caring physician
Dr Mclaughlin has been my endocrine doctor for 15 years and is amazing.
She's a wonderful doctor, knows her patients very well. Back office processes to support her work need to be more consistently delivered.
She listens to her patients and provides thoughtful medical advice. Nice person who cares about her patients.
Thank you for all that you do. You have no idea or maybe you might know how much this means to me to FINALLY have a diagnosis. For 2 years I have struggled and no one has been able to tell me what is wrong. I have had countless tests and have seen a plethora of doctors with nothing to show for it- until today. Thank you. Thank you. Thank you.
Very nice, answered all my questions
helpful
she'e
s very good knows her stuff
She is awesome!
Always looking out for me.
I really like Dr. McLaughlin but will be getting a doctor in Reno area & keeping Dr. McLaughlin when I come for other appts w/Stanford.
I was 1st seen by resident who clearly had identified my "problem" by the Clarity print out. She spent @ 10' before Dr. McLaughlin came in. Because most of the conversation was between them, like time was spent with me. When I spoke up, they both looked at me w/o responding then went back to their discussion. I realize this is the business of medicine but it's frustrating. Dr. McLaughlin spent at most 4' with me.
Dr. McLaughlin is the best endocrinologist I ever had - I commute from San Diego to see her every 3 months - I trust her and she is more like a friend. She looks at everything and make sure I understand.
The doctor didn't remember me/"my face" even though she's met me twice before. The intern also hadn't been prepped prior to coming into my room. His 2nd day in the endocrine dept.
Dr. McLaughlin is wonderful & is always very through and caring.
Love working with Dr. McLaughlin!
Dr. McLaughlin is the best!
Would definitely recommend Dr. McLaughlin.
Dr. McLaughlin is the best! I fly in from LA to keep her on my team of caregivers. Highest regard.
Dr. McLaughlin at her usual best
I live in San Diego - I can't find an endocrinologist as good as Dr. McLaughlin there. I fly up North for my appointments.
Dr. McLaughlin is very, good, conscientious & caring.
Dr. Tracey McLaughlin is simply the best.
Excellent experience of several years with Dr. McLaughlin receiving care & treatment. Takes care of all details and medical needs.
Great dr. and very nice person -
I get along great with all of the staff.
Is very excellent.
Tracey McLaughlin is my favorite physician of all time.
Best endocrinologist ever.
She exceeded my expectations. She was on top of my health plan and included me every step of the way. She made sure all my questions were answered.
Dr. McLaughlin was very informative. I certainly learned a lot from my first visit.
Excellent. Tracey McLaughlin MD MA.
Dr. McLaughlin is the best Dr. I have. She is kind, knowledgeable, treats me like an equal. She is passionate about her work and research.
Dr. McLaughlin is very through every time I come to see her.
Dr. McLaughlin is an excellent doctor. She always takes time to listen to my concerns.
Dr. McLaughlin is the best! She cares and listens.
Dr. McLaughlin is the best - bar none.
My doctor listens carefully & puts everything together to solve my endocrine problems.
Dr. McLaughlin is one of the most caring, thoughtful and informative physicians I have ever met. She always spends all the time necessary to completely answers all my questions. I wish all doctor's were as thoughtful, caring and informative.
Very grateful for Tracey and Anna Simmos.
Excellent experience of several years going to Endocrine Clinic of Stanford. Dr. Tracey McHaughlin for treatment after care empathy treatment helped our mother tremendously, appreciate the care!
Dr. McLaughlin is a very friendly, compassionate dr. She explains well and try to find a solution to any problems - she really understands her patients.
Doesn't seem prepared on case history before appointment.
Tracey McLaughlin is my 5th endocrinologist. The rest just didn't get it. Tracey's excellent!
Very kind and helpful.
One of the BEST if not THE BEST care provider of Stanford Hospital for me in my long and very productive association with the Hospital. Wish every specialist follows this care provider as a Role Model!
I had recently been through the ED & hospitalized in the CCO. I had come to see Dr. McLaughlin for diabetes care, but she diagnosed the condition that caused my hospitalization as a life threatening & continuing risk. She very realistically will have saved my life the next time I have an event.
Dr. McLaughlin always takes the time to review my complex history and make/adjust treatment plans.
Excellent provider.
We are very happy with Dr. McLaughlin & service she provides.
Dr. McLaughlin is a very good, compassionate doctor. She cares.
Dr. McLaughlin is an outstanding physician. She is extremely helpful, friendly, competent, and we are a team.
Dr. McLaughlin is 4-star - couldn't be more satisfied.
I live in San Jose, but I go to Stanford, to this doctor, to these nurse/assistant/because I know to receive max - attention to my health.
We have all the confidence in Dr. Tracey McLaughlin.
Dr. McLaughlin is a very kind and supportive provider who is very concerned about me & all her patients I'm sure.
Relies on data samples & information which are not representative of the health period under evaluation - and does not rely on computer results that are available.
Always a good experience with Dr. M!
Couldn't ask for a better dr.
Dr. Tracey is VERY knowledgeable, she showed genuine concern & I feel she is promptly investigating my health issues.
Very very good. The best.
Dr. McLaughlin is a excellent doctor that take time with her patients.
View More Patient Reviews
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records